Bentley Pharmaceuticals Aktie
WKN DE: 882798 / ISIN: US0826571079
|
13.08.2026 13:46:30
|
Brookfield Wealth Solutions Reports Lower Net Income In Q2
(RTTNews) - Thursday, Brookfield Wealth Solutions Ltd. (BNT) announced second-quarter financial results, reporting a decline in net income despite strong revenue growth in the period.
Net income totaled $149 million compared to $516 million in the prior year.
Total revenues for the quarter increased to $4.217 billion from last year's $3.037 billion, mainly due to higher net premiums and other policy revenue as well as net investment income, including funds withheld.
Distributable operating earnings were $488 million compared to $398 million in the second quarter of 2025.
BNT closed trading at $44.84, down 0.99 percent on the NYSE.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Bentley Pharmaceuticals Inc.
| Keine Nachrichten verfügbar. |